APTT3X™ Formulation Proves Effective in COVID-19 Brazil Clinical Trial
A non-prescription intranasal application of APTT3X™ formulation will DECREASE the risk of contracting COVID-19 by 150% . ROCKWALL, TEXAS, UNITED STATES, April 21, 2021 /EINPresswire.com/ -- The efficacy of the APTT3X™ formulation has been …